Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
1,8220
Trial Sponsor
Clinical Trial Start Date
2015
0Primary Completion Date
2017
0Study Completion Date
2018
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Device0
Intervention Name
SAPIEN S3 valve0
Interventional Trial Phase
Not Applicable0
Participating Facility
Official Name
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)0
Last Updated
April 8, 2021
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Study summary
Following completion of enrollment in the PARTNER II SAPIEN 3 intermediate risk trial, this trial provided continued access to treatment for subjects with severe aortic stenosis who were at intermediate surgical risk.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
